A prescription drug called Everolimus Tablet 10 mg is used to treat numerous cancers as well as non-cancerous diseases. Mammalian target of rapamycin, or mTOR, inhibitors like everolimus function by preventing the development and division of cells. Advanced renal cell carcinoma, pancreatic neuroendocrine tumours, and hormone receptor-positive, HER2-negative breast cancer are among the conditions it is frequently used to treat. Oral tablets containing 10 mg of everolimus are typically taken once day. Fatigue, mouth sores, diarrhoea, and a reduced white blood cell count are typical adverse reactions. Significant negative effects could include a higher risk of infections and slower wound healing. Healthcare workers should continuously monitor patients, and any alarming symptoms should be immediately reported for the proper management.
1. Everolimus is a mTOR inhibitor, which means it targets and shuts down the mTOR pathway, which is responsible for cell growth and proliferation.
2. Everolimus has a wide range of applications, including the treatment of hormone receptor-positive, HER2-negative breast cancer, advanced renal cell carcinoma, and pancreatic neuroendocrine tumours.
3. Everolimus Tablet 10 mg is administered orally, making it straightforward and simple to use.
4. Dosing routine for patients is made simpler by the tablet's normal once-daily use.
1. Everolimus aids in the prevention of tumour growth and may cause tumour stabilisation or reduction.
2. Prolonged progression-free survival: Studies in humans have demonstrated that the use of the cancer drug Everolimus can prolong progression-free survival in some cancer types.
3. Delay in disease progression: For certain people, Everolimus may prolong the time that their condition is stable.
4. Patient outcomes are improved because of Everolimus, which has shown promise in raising overall survival rates in some cancer instances.
5. Everolimus can be used in combination with other cancer treatments to increase the effectiveness of other therapies.
6. Everolimus is another medication used to stop organ rejection in some transplant recipients.
7. Reduced chance of angiomyolipoma: Angiomyolipomas, benign tumours connected to tuberous sclerosis complex, can shrink in size when treated with everolimus.
8. Treatment for non-cancerous illnesses: Everolimus is used to treat some non-cancerous conditions, including symptom alleviation and disease management.
It is crucial to remember that even though Everolimus Tablet 10 mg has a lot to offer in the treatment of both cancer and non-cancerous illnesses, there may also be risks and side effects. Healthcare workers should keep a tight eye on patients while they are receiving therapy, and any alarming symptoms should be immediately reported for proper management. Treatment choices should be discussed with oncologists or other medical professionals skilled in treating these cancers and illnesses.
1. Everolimus is used to treat advanced renal cell carcinoma (RCC), a form of kidney cancer that has progressed to other regions of the body.
2. Everolimus is used to treat advanced PNETs, a rare kind of pancreatic cancer. PNETs are pancreatic neuroendocrine tumours.
3. Breast Cancer in Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Status: Everolimus and exemestane are combined to treat advanced breast cancer in women with hormone receptor-positive, HER2-negative status.
4. Everolimus is used to treat Subependymal Giant Cell Astrocytoma (SEGA), a benign brain tumour connected to tuberous sclerosis complex (TSC).
5. When surgery is not an option, everolimus is used to treat renal angiomyolipoma, a benign kidney tumour connected to tuberous sclerosis complex (TSC).
1. Patients may feel weary or weak due to fatigue.
2. Everolimus has the potential to lead to oral ulcers or sores.
3. Diarrhoea: Diarrhoea is a potential symptom for some people.
4. Everolimus may make a person feel queasy or make them throw up.
5. White blood cell count decline: Everolimus can cause a white blood cell count decline, which raises the risk of infections.
6. Blood sugar levels rising: In some people, it may cause blood sugar levels to rise.
7. High cholesterol: Everolimus has the potential to raise cholesterol levels.
8. It may hinder the healing of wounds following surgery.
9. Interstitial lung disease: Interstitial lung disease is a rare side effect of everolimus that can make breathing difficult.
10. Everolimus has the potential to raise infection risk.
11. Angioedema risk: In extremely rare cases, it could result in angioedema, which causes swelling of the face, lips, tongue, or throat.
Healthcare personnel should keep a careful eye on patients while they are receiving treatment with Everolimus Tablet 10 mg. Any symptoms that warrant further investigation should be reported right away to the healthcare professional as the medication carries a potential for serious adverse effects. Oncologists or other healthcare professionals skilled in treating the specific disorders for which Everolimus is recommended should be consulted before making any treatment decisions.